Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer.
Jiajia SongLing BaiJianzhao ZhaiZhaodan XinLiting YouYi ZhouJuan ZhouBinwu YingPublished in: Journal of cancer research and clinical oncology (2022)
The frequency and proportion of ctDNA mutations are worth clinical attention in the prediction of therapeutic outcomes.